Angiogenesis inhibitors identified by cell-based high-throughput screening: Synthesis, structure-activity relationships and biological evaluation of 3-[(E)-styryl]benzamides that specifically inhibit endothelial cell proliferation

Orally available, in vivo active angiogenesis inhibitors which specifically inhibit endothelial cell proliferation are reported.